Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114


RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP.

Malathi K, Saito T, Crochet N, Barton DJ, Gale M Jr, Silverman RH.

RNA. 2010 Nov;16(11):2108-19. doi: 10.1261/rna.2244210. Epub 2010 Sep 10.


Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I.

Schnell G, Loo YM, Marcotrigiano J, Gale M Jr.

PLoS Pathog. 2012;8(8):e1002839. doi: 10.1371/journal.ppat.1002839. Epub 2012 Aug 2.


Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA.

Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M Jr.

Nature. 2008 Jul 24;454(7203):523-7. doi: 10.1038/nature07106. Epub 2008 Jun 11.


Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.

Kell A, Stoddard M, Li H, Marcotrigiano J, Shaw GM, Gale M Jr.

J Virol. 2015 Nov;89(21):11056-68. doi: 10.1128/JVI.01964-15. Epub 2015 Aug 26.


Small self-RNA generated by RNase L amplifies antiviral innate immunity.

Malathi K, Dong B, Gale M Jr, Silverman RH.

Nature. 2007 Aug 16;448(7155):816-9. Epub 2007 Jul 25.


Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.

Wang Y, Ye L, Wang X, Li J, Song L, Ho W.

Innate Immun. 2013;19(2):193-202. doi: 10.1177/1753425912460414. Epub 2012 Oct 11.


Links between recognition and degradation of cytoplasmic viral RNA in innate immune response.

Oshiumi H, Mifsud EJ, Daito T.

Rev Med Virol. 2016 Mar;26(2):90-101. doi: 10.1002/rmv.1865. Epub 2015 Dec 8. Review.


New insights into the role of RNase L in innate immunity.

Chakrabarti A, Jha BK, Silverman RH.

J Interferon Cytokine Res. 2011 Jan;31(1):49-57. doi: 10.1089/jir.2010.0120. Epub 2010 Dec 29. Review.


RNA PAMPs as Molecular Tools for Evaluating RIG-I Function in Innate Immunity.

Ireton RC, Wilkins C, Gale M Jr.

Methods Mol Biol. 2017;1656:119-129. doi: 10.1007/978-1-4939-7237-1_6.


RNase L and the NLRP3-inflammasome: An old merchant in a new trade.

Banerjee S.

Cytokine Growth Factor Rev. 2016 Jun;29:63-70. doi: 10.1016/j.cytogfr.2016.02.008. Epub 2016 Mar 10.


RNAs Containing Modified Nucleotides Fail To Trigger RIG-I Conformational Changes for Innate Immune Signaling.

Durbin AF, Wang C, Marcotrigiano J, Gehrke L.

MBio. 2016 Sep 20;7(5). pii: e00833-16. doi: 10.1128/mBio.00833-16.


DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.

Grünvogel O, Esser-Nobis K, Reustle A, Schult P, Müller B, Metz P, Trippler M, Windisch MP, Frese M, Binder M, Fackler O, Bartenschlager R, Ruggieri A, Lohmann V.

J Virol. 2015 Oct;89(20):10548-68. doi: 10.1128/JVI.01297-15. Epub 2015 Aug 12.


EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.

Zhu C, Xiao F, Hong J, Wang K, Liu X, Cai D, Fusco DN, Zhao L, Jeong SW, Brisac C, Chusri P, Schaefer EA, Zhao H, Peng LF, Lin W, Chung RT.

J Virol. 2015 Jul;89(13):6608-18. doi: 10.1128/JVI.00364-15. Epub 2015 Apr 15.


[Innate immune response to RNA virus infection].

Oshiumi H, Matsumoto M, Seya T.

Uirusu. 2011 Dec;61(2):153-61. Review. Japanese.


Cell-type-specific effects of RNase L on viral induction of beta interferon.

Banerjee S, Chakrabarti A, Jha BK, Weiss SR, Silverman RH.

MBio. 2014 Feb 25;5(2):e00856-14. doi: 10.1128/mBio.00856-14.


Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0.

Horner SM, Park HS, Gale M Jr.

J Virol. 2012 Mar;86(6):3112-20. doi: 10.1128/JVI.06727-11. Epub 2012 Jan 11.


IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.

Okamoto M, Oshiumi H, Azuma M, Kato N, Matsumoto M, Seya T.

J Immunol. 2014 Mar 15;192(6):2770-7. doi: 10.4049/jimmunol.1301459. Epub 2014 Feb 14.


Overexpression of the transcription factor Sp1 activates the OAS-RNAse L-RIG-I pathway.

Dupuis-Maurin V, Brinza L, Baguet J, Plantamura E, Schicklin S, Chambion S, Macari C, Tomkowiak M, Deniaud E, Leverrier Y, Marvel J, Michallet MC.

PLoS One. 2015 Mar 4;10(3):e0118551. doi: 10.1371/journal.pone.0118551. eCollection 2015.


Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2.

Saito T, Hirai R, Loo YM, Owen D, Johnson CL, Sinha SC, Akira S, Fujita T, Gale M Jr.

Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):582-7. Epub 2006 Dec 26.


A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses.

Oshiumi H, Miyashita M, Matsumoto M, Seya T.

PLoS Pathog. 2013;9(8):e1003533. doi: 10.1371/journal.ppat.1003533. Epub 2013 Aug 8.

Supplemental Content

Support Center